A Potential Turning Point for Celiac Disease: Teva’s TEV-408 Shows Promise in Phase 2a Trials

By Medical Science Correspondent For millions of individuals living with celiac disease, the current standard of care—a strict, lifelong gluten-free diet—is a demanding and often insufficient solution. Beyond the logistical…

Navigating the New Normal: Processing Equipment Market Shows Resilience in 2026 State of Industry Report

The food and beverage manufacturing landscape is undergoing a profound structural shift. As the industry moves past the unprecedented demand surge triggered by the COVID-19 pandemic, a new, more stable…